Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
T

T Man Pharmaceutical PCL
SET:TMAN

Watchlist Manager
T Man Pharmaceutical PCL
SET:TMAN
Watchlist
Price: 10.5 THB 1.94%
Market Cap: ฿4.2B
Write Note Create Alert Ask AI

Wall St Price Targets

TMAN Price Targets Summary
T Man Pharmaceutical PCL

Wall Street analysts forecast TMAN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMAN is 18.67 THB with a low forecast of 18.48 THB and a high forecast of 19.22 THB.

TMAN Lowest Forecast
Wall Street Target
฿18.48
76% Upside
TMAN Average Forecast
Wall Street Target
฿18.67
78% Upside
TMAN Highest Forecast
Wall Street Target
฿19.22
83% Upside
Lowest Forecast
Price Target
18.48 THB
76% Upside
Average Forecast
Price Target
18.67 THB
78% Upside
Highest Forecast
Price Target
19.22 THB
83% Upside
T Man Pharmaceutical PCL Competitors:
Price Targets

Revenue
Forecast

13% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
13% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 9%.

What are analyst estimates?

Gross Profit
Forecast

10% / Year
Past Growth
8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
10% / Year
Past Growth
8% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 8%.

What are analyst estimates?

Operating Income
Forecast

11% / Year
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 7%.

What are analyst estimates?

Pre-Tax Income
Forecast

10% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
10% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 5%.

What are analyst estimates?

Net Income
Forecast

10% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
10% / Year
Past Growth
3% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 3%.

What are analyst estimates?

Continue TMAN Research

Summary
TMAN intrinsic value, competitors valuation, and company profile.
DCF Valuation
TMAN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TMAN stock valuation using valuation multiples.
Wall St Estimates
TMAN price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TMAN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TMAN's stock price target?
Price Target
18.67 THB

According to Wall Street analysts, the average 1-year price target for TMAN is 18.67 THB with a low forecast of 18.48 THB and a high forecast of 19.22 THB.

What is the Revenue forecast for T Man Pharmaceutical PCL?
Projected CAGR
9%

Over the last 2 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 9%.

What is the Gross Profit forecast for T Man Pharmaceutical PCL?
Projected CAGR
8%

Over the last 2 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 8%.

What is the Operating Income forecast for T Man Pharmaceutical PCL?
Projected CAGR
7%

Over the last 2 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 7%.

What is the Pre-Tax Income forecast for T Man Pharmaceutical PCL?
Projected CAGR
5%

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 5%.

What is the Net Income forecast for T Man Pharmaceutical PCL?
Projected CAGR
3%

Over the last 2 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 3%.

Back to Top
ALPHA SPREAD
Follow us
Join 356,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett